Maren Lindner

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Multiple Sclerosis

Escherichia Coli

Cerebrospinal Fluid

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G Meuth, Catharina C Gross, Gerd Meyer Zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Luisa Klotz, Melanie Eschborn, Maren Lindner, Marie Liebmann, Martin Herold, Claudia Janoschka, Belén Torres Garrido, Andreas Schulte-Mecklenbeck, Catharina C Gross, Johanna Breuer, Petra Hundehege, Vilmos Posevitz, Béatrice Pignolet, Giulia Nebel, Shirin Glander, Nicole Freise, Judith Austermann, Timo Wirth, Graham R Campbell, Tilman Schneider-Hohendorf, Maria Eveslage, David Brassat, Nicholas Schwab, Karin Loser, Johannes Roth, Karin B Busch, Monika Stoll, Don J Mahad, Sven Guenther Meuth, Timothy J Turner, Amit Bar-Or, Heinz Wiendl
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects. Science translational medicine 11 (490) (2020)